NR4A1
Nuclear receptor subfamily 4immunitygroup A member 1
Also known as: GFRP1, HMR, N10, NAK-1, NGFIB, NR4A1_HUMAN, NUR77, TR3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P22736
- Gene
- NR4A1
- Ensembl
- ENSG00000123358
- Chromosome
- 12
- Canonical length
- 598 aa
- Protein class
- Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear membrane,Nucleoli fibrillar center,Nuclear speckles,Cytosol
OverviewNCBI Gene
This gene encodes a member of the steroid-thyroid hormone-retinoid receptor superfamily. Expression is induced by phytohemagglutinin in human lymphocytes and by serum stimulation of arrested fibroblasts. The encoded protein acts as a nuclear transcription factor. Translocation of the protein from the nucleus to mitochondria induces apoptosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
598 residues, UniProt reviewed canonical sequence.
>P22736|NR4A1
1 MPCIQAQYGT PAPSPGPRDH LASDPLTPEF IKPTMDLASP EAAPAAPTAL PSFSTFMDGY
61 TGEFDTFLYQ LPGTVQPCSS ASSSASSTSS SSATSPASAS FKFEDFQVYG CYPGPLSGPV
121 DEALSSSGSD YYGSPCSAPS PSTPSFQPPQ LSPWDGSFGH FSPSQTYEGL RAWTEQLPKA
181 SGPPQPPAFF SFSPPTGPSP SLAQSPLKLF PSQATHQLGE GESYSMPTAF PGLAPTSPHL
241 EGSGILDTPV TSTKARSGAP GGSEGRCAVC GDNASCQHYG VRTCEGCKGF FKRTVQKNAK
301 YICLANKDCP VDKRRRNRCQ FCRFQKCLAV GMVKEVVRTD SLKGRRGRLP SKPKQPPDAS
361 PANLLTSLVR AHLDSGPSTA KLDYSKFQEL VLPHFGKEDA GDVQQFYDLL SGSLEVIRKW
421 AEKIPGFAEL SPADQDLLLE SAFLELFILR LAYRSKPGEG KLIFCSGLVL HRLQCARGFG
481 DWIDSILAFS RSLHSLLVDV PAFACLSALV LITDRHGLQE PRRVEELQNR IASCLKEHVA
541 AVAGEPQPAS CLSRLLGKLP ELRTLCTQGL QRIFYLKLED LVPPPPIIDK IFMDTLPFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR4A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 800 nTPM
Expression across tissuesHPA
Tissue
- ovary: 800 nTPM
- adipose tissue: 671 nTPM
- heart muscle: 661 nTPM
- blood vessel: 606 nTPM
- adrenal gland: 530 nTPM
- fallopian tube: 454 nTPM
Single-cell type
- epicardial cells: 1,492 nCPM
- ovarian stromal cells: 1,173 nCPM
- endometrial luminal cells: 1,029 nCPM
- vascular smooth muscle cells: 825 nCPM
- breast secretory cells: 821 nCPM
- smooth muscle cells: 703 nCPM
Immune cell
- non-classical monocyte: 54 nTPM
- intermediate monocyte: 37 nTPM
- myeloid DC: 3.7 nTPM
- total PBMC: 2 nTPM
- classical monocyte: 1.3 nTPM
- memory B-cell: 0.9 nTPM
Brain region
- cerebellum: 288 nTPM
- cerebral cortex: 165 nTPM
- choroid plexus: 96 nTPM
- hypothalamus: 63 nTPM
- medulla oblongata: 49 nTPM
- white matter: 48 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.37
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cell migration involved in sprouting angiogenesis
- cellular response to corticotropin-releasing hormone stimulus
- cellular response to fibroblast growth factor stimulus
- cellular response to vascular endothelial growth factor stimulus
- detection of lipopolysaccharide
- endothelial cell chemotaxis
- fat cell differentiation
- inflammatory response
- macrophage activation
- negative regulation of cell cycle
- non-canonical inflammasome complex assembly
- positive regulation of apoptotic process
- positive regulation of endothelial cell proliferation
- positive regulation of transcription by RNA polymerase II
- protein import into nucleus
- regulation of transcription by RNA polymerase II
- regulation of type B pancreatic cell proliferation
- signal transduction
- skeletal muscle cell differentiation
- transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- lipopolysaccharide binding
- nuclear glucocorticoid receptor binding
- nuclear receptor activity
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Nuclear receptor subfamily 4 group A member 1-3
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
- Nuclear receptor subfamily 4 group A member 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR4A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR4A1 as an antibody target. Whether an autoantibody or antibody against NR4A1 could matter depends on whether native NR4A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR4A1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR4A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...